The Chulabhorn Royal Academy and Germany’s German Cancer Research Center (DKFZ) have signed their second academic cooperation agreement, extending their partnership for another five years. This collaboration covers knowledge exchange, joint research, curriculum development, technology transfer, and the advancement of medical, scientific, and innovation personnel.
The partnership involves the exchange of professors, students, and researchers, as well as the R&D of new treatments—particularly for pediatric cancers that do not respond to standard therapies. Advanced training in leading German institutions enhances the capabilities of Thai researchers and pharmaceutical developers.
Chulabhorn Royal Academy emphasizes the use of cutting-edge technology to develop targeted medicines, analyze disease mechanisms, and conduct effective laboratory drug trials. This approach supports creating new knowledge that can be applied to precise patient care.
The goal is to elevate cancer treatment, foster medical innovation, and increase access to effective therapies in Thailand through internationally standardized research and development processes.
For more information: Chulabhorn Research Institute
Link: www.cri.or.th
Since cannabis was taken off the list of narcotic drugs, there has been an increase in the number of foods, beverages, and snacks.
According to the Immigration Act 1979, in Section 4, the definition of “a person in charge of conveyance" means a ship's master or person responsible for supervising a vehicle
For foreigners wishing to extend their stay in Thailand, in the case of being family members of a Thai national (only parents, spouses, children, adopted children, or children of spouses), the Immigration Office has determined the requirements, as follows
EN
CN
DE
JP
TH